Article
Prevalence and spectrum of homologous recombination repair mutations in patients with metastatic prostate cancer from India.
The oncologist - 6 Mar 2026
Baskarane Hemavathi, Jain Rishabh, Divakar Mohit Kumar, Seth Amlesh, Nayak Brusabhanu, Bakhshi Sameer, Sahoo Ranjit Kumar, Kumar Akash, Sharma Aparna, Kaushal Seema, Haresh Kunhi Parambath, Hooda Vishakha, Vasudeva Payal, Singh Pranav Pratap, Agarwal Rishika, Vasundhara Sanskriti, Agarwal Neeraj, Batra Atul
Abstract excerpt
BACKGROUND: Alterations in genes involved in homologous recombination repair (HRR) occur in approximately 20%-25% of patients with metastatic prostate cancer and are associated with aggressive biology, poor outcomes, and potential sensitivity to poly (ADP-ribose) polymerase inhibitors (PARPi). However, frequency and variations in somatic HRR mutations in the Indian population are unknown. METHODS: We analyzed...
Topics
- Humans
- Male
- Prostatic Neoplasms
- India
- Mutation
- Middle Aged
- Recombinational DNA Repair
- Aged
- Prevalence
- Neoplasm Metastasis
